NRIX
Price
$18.86
Change
-$0.18 (-0.95%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.93B
34 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$7.63
Change
-$0.45 (-5.58%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.4B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs RLAY

Header iconNRIX vs RLAY Comparison
Open Charts NRIX vs RLAYBanner chart's image
Nurix Therapeutics
Price$18.86
Change-$0.18 (-0.95%)
Volume$15.53K
Capitalization1.93B
Relay Therapeutics
Price$7.63
Change-$0.45 (-5.58%)
Volume$26.37K
Capitalization1.4B
NRIX vs RLAY Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. RLAY commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (NRIX: $19.04 vs. RLAY: $8.07)
Brand notoriety: NRIX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 59% vs. RLAY: 54%
Market capitalization -- NRIX: $1.93B vs. RLAY: $1.4B
NRIX [@Biotechnology] is valued at $1.93B. RLAY’s [@Biotechnology] market capitalization is $1.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both NRIX and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 5 bullish, 3 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than RLAY.

Price Growth

NRIX (@Biotechnology) experienced а +2.97% price change this week, while RLAY (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.93B) has a higher market cap than RLAY($1.4B). NRIX YTD gains are higher at: 0.369 vs. RLAY (-4.610). NRIX has higher annual earnings (EBITDA): -248.7M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. NRIX (429M). RLAY has less debt than NRIX: RLAY (33.3M) vs NRIX (56.5M). NRIX has higher revenues than RLAY: NRIX (83.7M) vs RLAY (8.36M).
NRIXRLAYNRIX / RLAY
Capitalization1.93B1.4B138%
EBITDA-248.7M-322.8M77%
Gain YTD0.369-4.610-8%
P/E RatioN/AN/A-
Revenue83.7M8.36M1,002%
Total Cash429M596M72%
Total Debt56.5M33.3M170%
TECHNICAL ANALYSIS
Technical Analysis
NRIXRLAY
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOTTX10.500.09
+0.86%
Transamerica Mid Cap Value Opps I3
PRKCX7.400.03
+0.41%
PGIM Real Estate Income C
ACSHX31.610.12
+0.38%
Invesco Comstock R5
DBOZX24.56-0.02
-0.08%
BNY Mellon Balanced Opportunity Z
TWQCX17.38-0.03
-0.17%
Transamerica Large Cap Value C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.58%
KYMR - NRIX
65%
Loosely correlated
+1.46%
KURA - NRIX
55%
Loosely correlated
+1.63%
XNCR - NRIX
55%
Loosely correlated
+3.66%
OCUL - NRIX
54%
Loosely correlated
+6.14%
TYRA - NRIX
53%
Loosely correlated
+1.35%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+1.64%
NRIX - RLAY
52%
Loosely correlated
+0.58%
VIR - RLAY
52%
Loosely correlated
+8.08%
KURA - RLAY
51%
Loosely correlated
+1.63%
IMNM - RLAY
51%
Loosely correlated
+3.08%
BEAM - RLAY
50%
Loosely correlated
+2.49%
More